Overview

* Agilon Health Q3 2025 revenue beats analyst expectations despite a 1% yr/yr decline

* Net loss for Q3 2025 was $110 mln, missing analyst estimates

* Adjusted EBITDA loss of $91 mln in Q3 2025, missing analyst expectations

Outlook

* Agilon Health ( AGL ) expects 2025 revenue between $5.81 bln and $5.83 bln

* Company projects 2025 medical margin between -$5 mln and $15 mln

* Agilon Health ( AGL ) anticipates 2025 adjusted EBITDA between -$270 mln and -$245 mln

Result Drivers

* RISK ADJUSTMENT REVENUE - Lower-than-expected risk adjustment revenue impacted Q3 results due to incomplete data from a new market

* MARKET EXITS - Revenue and membership declines attributed to previously disclosed market exits

* TRANSFORMATION INITIATIVES - Progress in transformation initiatives, including operating cost reductions and improved payor contracting processes

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $1.44 $1.42

Revenue bln bln (16

Analysts

)

Q3 Net Miss -$110 -$68.42

Income mln mln (12

Analysts

)

Q3 Miss -$91 mln -$51.91

Adjusted mln (15

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 14 "hold" and 2 "sell" or "strong sell"

* The average consensus recommendation for the healthcare facilities & services peer group is "buy."

* Wall Street's median 12-month price target for agilon health inc is $1.35, about 40% above its November 3 closing price of $0.81

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)